SciSparc LtdSPRC
Price$4.55

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $1.3M-54.6% YoYTTM through 30 Jun 2025
Net Income -$7.5MTTM through 30 Jun 2025
Free Cash Flow -$5.1MTTM through 30 Jun 2025

Margins

Current
Gross Margin73.6%
EBITDA Margin-549.2%
Operating Margin-978.3%
Net Margin-572.1%

Returns

-164.8%ROA

Balance Sheet Health

Debt / Equity-4.52x
Current Ratio0.55x
Net Debt-$4.2Mnet cash position
Cash & Equivalents$1.5M

Quality Metrics

Piotroski F-Score1 / 9
FCF Margin-391.4%

Multi-Year Trend

Revenue
'22'23'24
FY2024: $1.3M
Diluted EPS
'18'19'20'21'22'23'24
FY2024: $1.28

Dividend

No dividend

Capital Allocation

Capex Intensity0.6%

Segment Performance

No segment data available.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.